Reunion Neuroscience Current Cash

Reunion Neuroscience (REUN) currently reports a current cash of $27M as of March 2023. That compares with $64M in the prior-year period — down 57.3% year over year. Use the charts on this page to explore Reunion Neuroscience's current cash history and peer comparisons.

Reunion Neuroscience's current cash decreased from $64M to $27M — a 57.3% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Reunion Neuroscience reported $27M in current cash as of March 2023. That compares with $64M in the prior-year period — down 57.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $27M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Reunion Neuroscience, and consider following REUN for alerts when major investors trade the stock.

Reunion Neuroscience is classified in the Healthcare sector. On current cash, it currently shows $27M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing REUN with unrelated industries.